Related Experiment Video
Updated: Aug 1, 2025
06:32
Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.3K
A Pilot Study of Accelerometer-Based Biometric Data Collection among Patients Undergoing Locoregional Therapies.
Karim Oueidat1, Grayson L Baird1, Michael H Bernstein1
1Department of Diagnostic Imaging, the Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Journal of Vascular and Interventional Radiology : JVIR
|April 26, 2023
Summary
Wearable activity trackers (WATs) effectively measured patient recovery after cancer locoregional therapies (LRTs). WATs captured dynamic activity changes missed by traditional surveys, aiding recovery monitoring.
Area of Science:
- Oncology
- Medical Technology
- Rehabilitation
Background:
- Locoregional therapies (LRTs) are common cancer treatments.
- Assessing patient recovery post-LRT often relies on subjective surveys.
- Objective, dynamic monitoring of recovery is needed.
Purpose of the Study:
- To evaluate the feasibility of using wearable activity trackers (WATs) for measuring patient recovery after LRTs.
- To compare WAT data with patient-reported outcomes from the SF-36 survey.
- To determine if WATs can capture periprocedural recovery dynamics.
Main Methods:
- Twenty adult cancer patients wore a WAT for 7 days pre-LRT (baseline) and up to 30 days post-LRT.
- Daily step counts were continuously recorded.
- The Short Form 36-Item Health Survey (SF-36) was administered pre- and post-LRT.
Main Results:
- Mean daily steps decreased from 4,850 (baseline) to 2,000 (immediately post-LRT).
- Steps recovered to approximately 4,300 within 10 days (P < .001).
- No significant changes were observed in SF-36 scores (P > .10).
Conclusions:
- Wearable activity trackers provide dynamic periprocedural data for cancer patient recovery.
- WATs capture recovery trends not reflected in standard survey assessments.
- WATs show potential for monitoring recovery after interventional oncologic procedures.
